Healthcare technology company Stellar Health acknowledges Jonathan Blum for his advisory contributions. Blum previously served as Principal Deputy Administrator for the Centers for Medicare & Medicaid Services (CMS) under the Obama Administration and resumed his role at CMS in June 2021 under the Biden Administration.
Stellar Health and Accurate Diagnostic Laboratories have partnered to support healthcare providers in advancing value-based care (VBC). The collaboration aims to equip practices with data-driven tools to enhance patient health outcomes and sustain private practice operations. Both companies focus on integrating diagnostic solutions to streamline clinical decision-making for providers.
Stellar Health raises **$10 million** to advance **value-based care** models in primary care. The company targets inefficiencies in fee-for-service systems, where providers are pressured to prioritize visit volume over patient outcomes. It aims to help practitioners focus on quality care and illness prevention by addressing entrenched industry behaviors.
Stellar Health secures a $10 million Series A round to develop tools that support physicians in achieving value-based care objectives. The oversubscribed funding will likely accelerate product innovation targeting healthcare providers. The company focuses on aligning physician incentives with broader value-based care frameworks.
Stellar Health supports independent healthcare providers navigating the shift to value-based care. The transition disrupts traditional business models, forcing consolidation as smaller practices struggle to adapt. The company aims to mitigate these challenges by offering tools and resources tailored to value-based frameworks.

Stellar Health: Enhancing healthcare quality and financial performance with innovative tech solutions.